Loading...
13 US Hyperglycemics Reports
Country Covered: US
Study Period: 2019 - 2029
Major Players: Janssen Pharmaceutical, Eli Lilly, AstraZeneca Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals, Astellas
Country Covered: US
Study Period: 2019- 2029
Major Players: Sanofi Aventis, Bristol-Myers Squibb, Glenmark Pharmaceuticals, Takeda Pharmaceuticals, Merck & Co., Inc.
Country Covered: US
Study Period: 2019 - 2029
Major Players: Sanofi S.A., Novo Nordisk A/S, Eli Lilly and Company, Pfizer Inc, Biocon Limited
Country Covered: US
Study Period: 2018 - 2029
Major Players: Novo Nordisk, Glenmark, Novartis, KISSEI, Biocon
Country Covered: US
Study Period: 2018 - 2029
Major Players: Mylan, Lupin, Merck and Co., Pfizer Inc., Sanofi Aventis
Country Covered: US
Study Period: 2019- 2029
Major Players: Glenmark Pharmaceuticals, Novartis, Kissei Pharmaceuticals, Biocon, Novo Nordisk A/S
Country Covered: US
Study Period: 2019 - 2029
Major Players: Janssen Pharmaceuticals, Eli Lilly, Bristol Myers Squibb, AstraZeneca Pharmaceuticals, Astellas
Country Covered: US
Study Period: 2019 - 2029
Major Players: Abbott, Sanofi , Mylan Inc, Lupin, Aurobindo Pharma
Country Covered: US
Study Period: 2018 - 2029
Major Players: Sanofi Aventis, Novo Nordisk AS, Biocon, Eli Lilly and Company, Julphar
Country Covered: US
Study Period: 2019 - 2029
Major Players: Novo Nordisk, Sanofi, Eli Lilly, Biocon, Wockhardt
Country Covered: US
Study Period: 2019 - 2029
Major Players: Novo Nordisk A/S, Eli Lilly and Company, Pfizer Inc., Sanofi, Biocon
Country Covered: US
Study Period: 2019- 2029
Major Players: Sanofi Aventis, Pfizer Inc., Merck & Co., Inc., Torrent Pharma, Dr. Reddy's Laboratories
Country Covered: US
Study Period: 2018 - 2029
Major Players: Bristol Myers Squibb, Glenmark Pharmaceuticals, Takeda, Sanofi Aventis, Merck and Co.
